MEDANTA1,457.00

Global Health Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHAPOLLOHOSPFORTISGLAXOANTHEMAJANTPHARMIPCALABABBOTINDIAMcap ₹39,148 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation172.7193.7222.5
+ Finance Costs73.965.379.1
+ Interest Income-59.7-70.3-85.9
+ Share-based Payments0.20.038.3
+ Unrealised FX (Gain) / Loss1.7-0.42.6
+ Other Non-cash Items5.718.3-53.2
+ Other Reconciling Items26.82.30.0
Changes in Working Capital
+ Inventories-6.5-0.3-11.8
+ Trade Receivables — Current-48.4-94.9-130.3
+ Trade Payables — Current1.812.653.6
+ Other Non-current Liabilities-5.70.00.0
+ Provisions — Non-current0.014.50.0
Cash from Operating Activities
Profit Before Tax (per I/S)627.1647.3715.0720.1
+ Total Adjustments (incl. Working Capital)162.5140.7114.8
Cash from Operations (pre-tax)789.5788.0829.8
+ Other Inflows / (Outflows) — Operating0.00.04.0
+ Income Taxes Paid177.5164.2119.4
Cash from Operating Activities612.1623.8714.4
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)278.6516.5838.2
+ Disp of Fixed Assets1.43.00.8
+ Acq of Other Long-term Assets0.0131.40.0
+ Purchase of Investments (Equity / Debt)0.02.70.0
+ Interest Received — Investing58.967.277.6
+ Other Inflows / (Outflows) — Investing-222.6-140.5-305.3
Cash from Investing Activities-440.8-720.9-1,065.1
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.0
+ Proceeds from Other Equity Instruments0.01.30.0
+ Proceeds from Borrowings136.3149.2368.7
+ Repayment of Borrowings582.2183.412.1
+ Payment of Lease Liabilities11.310.646.7
+ Interest Paid56.753.738.8
+ Dividends Paid0.00.013.4
+ Other Inflows / (Outflows) — Financing0.00.0-9.8
Cash from Financing Activities-513.9-97.2247.9
Net Changes in Cash (pre-FX)-342.6-194.4-102.9
Net Changes in Cash-342.6-194.4-102.9
Closing Cash424.6230.2
Reference Items
EBITDA799.1877.1919.1978.8
EBITDA Margin %24.4023.7520.8420.90
Free Cash Flow (CFO − Capex)333.5107.2-123.8-123.8
Free Cash Flow to Equity-37.9699.6
Free Cash Flow per Basic Share12.413.99-4.61-4.61
Cash Flow to Net Income1.281.301.29
Cash Paid for Taxes177.5164.2119.4
Cash Paid for Interest56.753.738.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.